EIT Health will invest up to €2 million in two start-ups that offer the most effective and disruptive solutions to address either Women’s Health or Digital Therapeutics.Applications for the Wild Card programme are open until 9th February 2020.
19 December, 2019
Dr George Frodsham, CEO and founder of innovative MedTech company, MediSieve, has been selected as one of MIT Technology Review’s Innovators Under 35 Europe 2019.
18 December, 2019
Somerset, N.J. & Birmingham, Ala.– December 10, 2019 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that it has completed clinical production of Bridge Therapeutics Inc.’s (Bridge) opioid addiction development therapeutic product, BT-219, and executed an Exclusive Licensing Agreement to use Catalent’s proprietary Zydis® orally disintegrating tablet (ODT) technology. Bridge currently intends to seek approval from the U.S. FDA for BT-219 under the “505(b)(2)” regulatory submission pathway as well as a possible future single entity buprenorphine product.
17 December, 2019
Start Codon cohort companies to receive One Nucleus membership benefits
16 December, 2019
The topic of this month’s newsletter from Drug Discovery Today is “The Best of 2019”.
16 December, 2019
A team of molecular and structural biologists from Nanyang Technological University, Singapore (NTU Singapore) have found a potential new route to disabling respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) after elucidating the structure of one of its key components.
09 December, 2019
Mogrify platform recognized as having potential to transform future development of new medicines at prestigious awards ceremony. Mogrify Chair receives Lifetime Achievement Award for contributions to biologics discovery and development
06 December, 2019
The $4M expansion has tripled the facility’s footprint to approximately 25,000 sq. ft, significantly expanding capacity and supporting MedPharm’s continued commitment to the topical and transdermal market.
04 December, 2019
Horizon’s HAP1 cell line to be integrated in the HPA Cell Atlas program. Knockout cell models from Horizon chosen based on consistency and reproducibility demonstrated in validation studies. Agreement will expand open access resource, supporting genetic research globally
04 December, 2019
SparingVision awarded First Prize in the Biotech category during the European EIT Health Summit held in Paris from 2 to 3 December
04 December, 2019
18 month project in collaboration with University of Leeds and Medicines Discovery Catapult will deliver a new compound for treatment of thrombosis. Currently available anticoagulants carry high risk of bleeding
03 December, 2019
Hull, UK, 3rd December 2019 - RB plc, the leading global consumer health, hygiene and home company, today opens its state-of-the-art Science and Innovation Centre (“S&I Centre”) in Hull.
03 December, 2019
Professor René Medema, Director of Research of the Netherlands Cancer Institute, has been appointed the new chair of EU-LIFE, an alliance of thirteen leading life science institutes in Europe, as of 1 January 2020.
02 December, 2019